2014 European guideline on the management of syphilis

M. Janier; V. Hegyi; N. Dupin; M. Unemo; G.S. Tiplica; M. Potocnik; P. French; R. Patel

doi:10.5114/dr.2015.55318

eISSN: 2084-9893
ISSN: 0033-2526

Dermatology Review/Przegląd Dermatologiczny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

5/2015
vol. 102

Send email

Copy url:

abstract:

Special paper

2014 European guideline on the management of syphilis

M. Janier

,

V. Hegyi

,

N. Dupin

,

M. Unemo

,

G.S. Tiplica

,

M. Potocnik

,

P. French

,

R. Patel

Przegl Dermatol 2015, 102, 459–475

DOI: https://doi.org/10.5114/dr.2015.55318

Online publish date: 2015/10/29

View full text Get citation

PlumX metrics:

Reprinted and translated from Journal of the European Academy of Dermatology and Venereology 28 (2014) “2014 European guideline on the management of syphilis” pp. 1581-1593, Copyright 2014 with permission © 2014 European Academy of Dermatology and Venereology.

Background. Syphilis remains a major public health problem in Europe (both in Eastern Europe since the 1990’s and in Western Europe since the re-emergence of the disease in the late 1990’s-early 2000’s).

Methods. This guideline is an update of the IUSTI: 2008 European guideline on the management of syphilis and is produced by the European Guideline Editorial Board (http://www.iusti.org/regions/Europe/pdf/2013/Editorial_Board.pdf) and EDF Guideline Committee.

Results. It provides recommendations concerning the diagnosis and management of syphilis in Europe. Major advances include (1) broader use of PCR, immunohistochemistry, subtyping of the etiological agent Treponema pallidum subspecies pallidum, new treponemal tests, and rapid-point-of-care (POC) tests detecting both treponemal and non-treponemal antibodies, (2) more flexible options for screening (TT-treponemal test – first or NTT – non treponemal test – first or both TT and NTT), and (3) procaine penicillin is no longer the first line therapy option in any phase of the disease, i.e. long acting penicillin G (i.e. benzathine penicillin G-BPG) is the only first line therapy regimen in early syphilis and in late latent syphilis.

Conclusions. Syphilis is a disease that is relatively easy to detect by appropriate serological tests, however, all laboratory results should be considered together with clinical data and sexual risk anamnesis. Syphilis is also easy to treat with BPG. A major concern about the supply of BPG in many European countries could threaten the efficacy of the policies of eradication of the disease in Europe.

keywords:

2014 European guideline on the management of syphilis

M. Janier , V. Hegyi , N. Dupin , M. Unemo , G.S. Tiplica , M. Potocnik , P. French , R. Patel

syphilis, diagnosis, treatment, European guideline

M. Janier

,

V. Hegyi

,

N. Dupin

,

M. Unemo

,

G.S. Tiplica

,

M. Potocnik

,

P. French

,

R. Patel